Thrombosis in flowing blood

Slides:



Advertisements
Similar presentations
HEMOSTASIS Hemostasis
Advertisements

HEMOSTASIS (STEPS OF)‏
Biomedical R&D Folie (slide) 1 Saratin - mechanism of action vWF Platelet.
Coagulation Just the basics.... Three steps Vasoconstriction Platelet plug formation Fibrin clot formation.
HEMOSTASIS. Due to damaged blood vessels Events that stop bleeding.
HEMOSTASIS – Stoppage of Blood Flow.
Thrombin By: Bailey Goodyear, Mike Kiefer, Yami Hernandez.
Damaged Blood Vessels. On vessel injury
Blood Course By Dr. Khidir Abdel Galil.
Section 10: Nutrients and their functions Vitamin K and blood clot formation 01/27/06.
Secondary Hemostasis Part One MLAB Coagulation Keri Brophy-Martinez.
MLAB 1227: C OAGULATION K ERI B ROPHY -M ARTINEZ Overview of Hemostasis: Part Two.
HEMOSTASIS Primary hemostasis.
Arrange the slides in the proper order then change the background to a color other than white to check yourself. Close without saving to return to orginal.
Thrombosis and Haemostasis Café Cardiologique 29/10/2014.
Blood Coagulation Dr Mahvash Khan MBBS, MPhil Hemostasis The third mechanism by which Hemostasis can be achieved is by formation of a blood clot.
Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRγ deficiency by Pierre Mangin, Cindy L. Yap, Christelle Nonne, Sharelle A. Sturgeon,
Principles of Blood Coagulation
2nd Year Medicine- Blood Module May 2008
FIBRINOLSIS SYSTEM Ahmad Shihada Silmi Msc, FIBMS IUG
HEMOSTASIS BY: SATHISH RAJAMANI. ASSOCIATE PROFESSOR.
by Bernhard Nieswandt, and Johan W. M. Heemskerk
Nat. Rev. Nephrol. doi: /nrneph
L/O – What causes atherosclerosis?
Not fibrin(ogen), but fibrinogen or fibrin
by Matt W. Goschnick, Lai-Man Lau, Janet L. Wee, Yong S. Liu, P
Occlusive thrombi arise in mammals but not birds in response to arterial injury: evolutionary insight into human cardiovascular disease by Alec A. Schmaier,
Polyphosphates rock! A role in thrombosis?
Role of high shear rate in thrombosis
Thanks for the complement (inhibitor)‏
GLEE-ful for sickle cell pain?
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
“Radical” model of thrombosis
PMNs deliver first aid to clot
Figure 1 Mechanism of thrombus formation during ST-segment
Important port for SHIP-1 at Dok-3
Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2−/− mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation.
Zinc fingers poke zebrafish, cause thrombosis!
Rap1-GTP–interacting adaptor molecule (RIAM) is dispensable for platelet integrin activation and function in mice by Simon Stritt, Karen Wolf, Viola Lorenz,
Impaired activation of platelets lacking protein kinase C-θ isoform
Platelet Ca2+ responses coupled to glycoprotein VI and Toll-like receptors persist in the presence of endothelial-derived inhibitors: roles for secondary.
ROCK and Rho(ll) in bone marrow
Blood #2.
by J. Evan Sadler Blood Volume 112(1):11-18 July 1, 2008
Cobalt hematoporphyrin inhibits CLEC-2–podoplanin interaction, tumor metastasis, and arterial/venous thrombosis in mice by Nagaharu Tsukiji, Makoto Osada,
IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation by Melanie Antl, Marie-Luise von Brühl, Christina Eiglsperger,
Paul A. Gurbel, and Udaya S. Tantry JCHF 2014;2:1-14
Diverging signaling events control the pathway of GPVI down-regulation in vivo by Tamer Rabie, David Varga-Szabo, Markus Bender, Rastislav Pozgaj, Francois.
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations by Bénédicte Dumont, Dominique Lasne, Chantal Rothschild,
Drugs Affecting Blood.
A function-blocking PAR4 antibody is markedly antithrombotic in the face of a hyperreactive PAR4 variant by Shauna L. French, Claudia Thalmann, Paul F.
R. Clive Landis, PhD, George Asimakopoulos, Mike Poullis, Dorian O
Figure 1 Mechanisms of platelet adhesion and aggregation
Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects by Constance C. F. M. J. Baaten, Frauke Swieringa, Tomasz Misztal,
Volume 81, Issue 12, Pages (June 2012)
Protein kinase Cα: disease regulator and therapeutic target
Nat. Rev. Cardiol. doi: /nrcardio
ELMO1 deficiency enhances platelet function
HEMOSTASIS (Stages of Blood Clotting)‏
Actin assembly in response to thrombin.
by Alyssa J. Moroi, Nicole M. Zwifelhofer, Matthew J. Riese, Debra K
Hemostasis Hemostasis depends on the integrity of Blood vessels
Section B: Science update
Trousseau's syndrome: multiple definitions and multiple mechanisms
Heparin-induced thrombocytopenia
How I treat disseminated intravascular coagulation
A binding relationship with thrombin
Interaction of platelet-decorated VWF strings with leukocytes and infected red blood cells in vitro. Interaction of platelet-decorated VWF strings with.
Myeloproliferative neoplasms and thrombosis
A schematic diagram showing the mechanism by which L5 triggers platelet activation and aggregation. A schematic diagram showing the mechanism by which.
Presentation transcript:

Thrombosis in flowing blood by Alec A. Schmaier, and Alvin H. Schmaier Blood Volume 114(4):754-756 July 23, 2009 ©2009 by American Society of Hematology

Mechanisms for thrombin generation by collagen in vivo. Mechanisms for thrombin generation by collagen in vivo. In flowing blood where there are shear forces, platelets adhere to exposed collagen. Slowed platelets additionally bind to collagen via glycoprotein VI (GPVI). The GPVI-collagen interaction results in platelet activation. Independently, exposed collagen supports zymogen factor XII (XII) autoactivation to enzymatic factor XIIa (XIIa). XIIa initiates thrombin generation through a series of proteolytic reactions. Thrombin then stimulates platelets by activating its receptors, protease activated receptor 1 (PAR1) and 4 (PAR4). PAR activation and GPVI signaling jointly contribute to a platelet thrombus, which amplifies into a fibrin clot and arterial vessel occlusion. Alec A. Schmaier, and Alvin H. Schmaier Blood 2009;114:754-756 ©2009 by American Society of Hematology